Cardiovascular Effects of Music Versus Guided Mindfulness
CMM
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to examine how listening to music compares to guided mindfulness in affecting blood pressure, heart rate, and feelings of anxiety in healthy adults. The investigators aim to determine whether one of these approaches is more effective in reducing these variables. Additionally, the study will explore whether personal traits or preferences, measured using questionnaires, influence how participants respond to music or mindfulness. Based on previous clinical findings, the researchers hypothesize that listening to music will lead to greater reductions in blood pressure and heart rate compared to guided mindfulness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedStudy Start
First participant enrolled
April 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 24, 2026
April 1, 2026
2 months
December 12, 2025
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Blood Pressure
The investigators will compare changes in systolic and diastolic blood pressure between the curated music playlist and guided mindfulness interventions using an automated oscillometric upper arm blood pressure monitor with measurements taken at 10-minute intervals.
0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
Changes in Heart Rate
The investigators will compare changes in heart rate between the curated music playlist and guided mindfulness interventions using an automated oscillometric upper arm blood pressure monitor with measurements taken at 10-minute intervals.
0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
Secondary Outcomes (9)
Changes in Beat-to-Beat Blood Pressure (Finapres NOVA)
0 to 40 minutes during each 40-minute intervention session.
Changes in Heart Rate (Finapres NOVA, Electrocardiogram-derived)
0 to 40 minutes during each 40-minute intervention session.
Change from Baseline in STAI-Y 1
Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
Change from Baseline in Edmonton Symptom Assessment System (ESAS)
Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
Barcelona Music Reward Questionnaire (BMRQ)
Baseline
- +4 more secondary outcomes
Study Arms (2)
Music Intervention First
EXPERIMENTALParticipants randomized to this arm will receive a 40-minute Music Listening intervention in the first period, followed by a 20-minute washout period, and then receive a 40-minute Guided Mindfulness intervention in the second period.
Mindfulness Intervention First
EXPERIMENTALParticipants randomized to this arm will receive a 40-minute Guided Mindfulness intervention in the first period, followed by a 20-minute washout period, and then receive a 40-minute Music Listening intervention in the second period.
Interventions
Participants will listen to a 40-minute playlist, curated by the research team, through noise-cancelling headphones. The playlist will simultaneously be played in the room through speakers.
Participants will engage in a structured mindfulness session led by a member of the research team with experience in mindfulness-based practices.
Eligibility Criteria
You may qualify if:
- Normal baseline blood pressure (systolic BP \< 120 mmHg and diastolic BP \< 80mmHg).
- Abstention from caffeine intake for at least 12 hours before the study session and throughout the session, as caffeine may influence cardiovascular measurements.
- Abstention from using nicotine or tobacco products for at least 1 hour before the study session and throughout the session, as these substances may influence cardiovascular measurements.
You may not qualify if:
- Significant hearing impairments that cannot be improved with hearing aids or sound amplification.
- Current use of medications that could affect blood pressure.
- History of hypertension or cardiovascular disease.
- Diagnosis of active substance use disorder, or reported patterns of alcohol, cannabis, or recreational/non-prescribed substance use likely to affect cardiovascular function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyle Greenway, MD
Sir Mortimer B. Davis - Jewish General Hospital, McGill University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Psychiatrist
Study Record Dates
First Submitted
December 12, 2025
First Posted
January 14, 2026
Study Start
April 10, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Due to the sensitive nature of the data and the small sample size, which poses a risk of participant identification, the data will not be shared.